Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
54.91
-2.52 (-4.39%)
At close: Sep 12, 2025, 4:00 PM EDT
54.51
-0.40 (-0.73%)
After-hours: Sep 12, 2025, 7:52 PM EDT
Celcuity Market Cap
Celcuity has a market cap or net worth of $2.33 billion as of September 12, 2025. Its market cap has increased by 272.04% in one year.
Market Cap
2.33B
Enterprise Value
2.26B
1-Year Change
272.04%
Ranking
Category
Stock Price
$54.91
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $138.93M to $2.33B, an increase of 1,576.88%. That is a compound annual growth rate of 42.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 2.33B | 379.33% |
| Dec 31, 2024 | 486.03M | 32.18% |
| Dec 29, 2023 | 367.71M | 21.13% |
| Dec 30, 2022 | 303.56M | 54.26% |
| Dec 31, 2021 | 196.78M | 108.63% |
| Dec 31, 2020 | 94.32M | -13.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |